New technology enables identification of biomarkers for a wide range of diseases

Share it

The new, highly sensitive Luminex Multiplex Glycan Array enables the kind of volume needed to establish associations between antibody levels in our blood to these complex sugars, or glycans, and conditions from cancer to autoimmune  and dementia, they report in the journal Nature Communications.

“For many diseases that kill us every day, there still are no good ,” says Dr. Jin-Xiong She, director of the Center for and Genomic Medicine at the Medical College of Georgia at Augusta University and Georgia Research Alliance Eminent Scholar in Genomic Medicine.

Sugar coating on our cells is hardly icing, rather essential to cell health and ours. It helps cells know what other cells to bind to; its adhesive nature even helps them stick to other cells. It can help ensure a negative charge on the cell surface that keeps cell contents inside and provide protection from bacteria or viruses. It helps ensure that the proteins our cells make stay on task. It even helps our immune system recognize our cells as us.

But the sugar coating can also, often inexplicably, become a target for our immune system, which can dramatically alter cell function and lead to disease.

Like our cells, the beads in the new array are sugar coated. By exposing patient blood or serum to them, the scientists can see which glycans the patient is making against and how much they are making, looking for trends that could predict disease course, even potentially one day diagnose their disease.

In fact, the scientific team led by She has already used the array to identify a potential biomarker for high risk of ovarian cancer relapse following surgery and standard chemotherapy regimens.

Read full article here.

 

Post Author: Nicholi Avery

Research, neuroscience, cognitive science, theoretical physics, biology, philosophy, and psychology.

Leave a Reply

Your email address will not be published. Required fields are marked *